A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy

What is the purpose of this trial?

The purpose of this study is evaluate the efficacy of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocation who have failed at least 1 previous treatment.



Incyte Corporation

Start Date: 03/20/2017

End Date: 04/30/2018

Last Updated: 02/22/2018

Study HIC#: 1610018578

Get Involved

For more information about this study, contact:
Kamil Sadowski
+1 203-785-6661
kamil.sadowski@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image